Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Go back to Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fabien Corp (NASDAQ: FBIO) Delayed: 2.51 --0 (-0%)
Previous Close $2.51    52 Week High $4.66 
Open $2.50    52 Week Low $2.01 
Day High $2.57    P/E N/A 
Day Low $2.47    EPS $0.00 
Volume 414,776